No Insurance Required!
Click to Sign Up Today
A local research site is enrolling healthy adults 50–64 years old for a clinical research study evaluating an investigational, variant-adapted COVID-19 vaccine.
You may qualify if you are between 50 and 64 and in generally good health.
COVID-19 continues to evolve, and updated vaccines are being developed to better match circulating variants. Research like this helps scientists learn how well newer formulations may work in healthy adults without underlying high-risk conditions.
By participating, you can help advance the understanding of COVID-19 prevention and contribute to the development of updated vaccine options.
Elixia Health is seeking volunteers ages 50–64 to take part in a research study evaluating an investigational COVID-19 vaccine designed to help researchers better understand protection against circulating variants.
By joining, you’ll receive study-related care at no cost and play an important role in supporting research that may guide future COVID-19 vaccination strategies.
Why Join a Clinical Research Study
• Receive study-related care from qualified professionals
• Support the development of future vaccine options
• Contribute to important public health research
• Compensation may be provided for time and participate
Elixia’s Commitment to Our Research Studies
At Elixia, we are dedicated to advancing vaccine research through carefully conducted clinical research studies. Our mission is to help support the development of innovative treatment options for COVID-19.
No results found.